These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 24521710)

  • 1. A global profile of gene promoter methylation in treatment-naïve urothelial cancer.
    Ibragimova I; Dulaimi E; Slifker MJ; Chen DY; Uzzo RG; Cairns P
    Epigenetics; 2014 May; 9(5):760-73. PubMed ID: 24521710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis.
    Erichsen L; Ghanjati F; Beermann A; Poyet C; Hermanns T; Schulz WA; Seifert HH; Wild PJ; Buser L; Kröning A; Braunstein S; Anlauf M; Jankowiak S; Hassan M; Bendhack ML; Araúzo-Bravo MJ; Santourlidis S
    Sci Rep; 2018 Feb; 8(1):3477. PubMed ID: 29472622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA hypermethylation on multiple CpG islands associated with increased DNA methyltransferase DNMT1 protein expression during multistage urothelial carcinogenesis.
    Nakagawa T; Kanai Y; Ushijima S; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2005 May; 173(5):1767-71. PubMed ID: 15821584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer.
    Habuchi T; Takahashi T; Kakinuma H; Wang L; Tsuchiya N; Satoh S; Akao T; Sato K; Ogawa O; Knowles MA; Kato T
    Oncogene; 2001 Jan; 20(4):531-7. PubMed ID: 11313984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
    Kunze E; Wendt M; Schlott T
    Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant cell adhesiveness due to DNA hypermethylation of KLF11 in papillary urothelial carcinomas.
    Tsumura K; Fujimoto M; Tian Y; Kawahara T; Fujimoto H; Maeshima AM; Nakagawa T; Kume H; Yoshida T; Kanai Y; Arai E
    Exp Mol Pathol; 2024 Jun; 137():104908. PubMed ID: 38824688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
    Palsgrove DN; Taheri D; Springer SU; Cowan M; Guner G; Mendoza Rodriguez MA; Rodriguez Pena MDC; Wang Y; Kinde I; Ricardo BFP; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
    Hum Pathol; 2019 Mar; 85():1-9. PubMed ID: 30447301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure.
    Yang TY; Hsu LI; Chiu AW; Pu YS; Wang SH; Liao YT; Wu MM; Wang YH; Chang CH; Lee TC; Chen CJ
    Environ Res; 2014 Jan; 128():57-63. PubMed ID: 24268366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival.
    Jou YC; Tsai YS; Chen SY; Hsieh HY; Tsai HT; Tzai TS
    Virchows Arch; 2016 Jun; 468(6):733-40. PubMed ID: 27003158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.
    McInnes T; Zou D; Rao DS; Munro FM; Phillips VL; McCall JL; Black MA; Reeve AE; Guilford PJ
    BMC Cancer; 2017 Mar; 17(1):228. PubMed ID: 28351398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue.
    Wolff EM; Chihara Y; Pan F; Weisenberger DJ; Siegmund KD; Sugano K; Kawashima K; Laird PW; Jones PA; Liang G
    Cancer Res; 2010 Oct; 70(20):8169-78. PubMed ID: 20841482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of Elf5 is associated with epithelial-mesenchymal transition in urothelial cancer.
    Wu B; Cao X; Liang X; Zhang X; Zhang W; Sun G; Wang D
    PLoS One; 2015; 10(1):e0117510. PubMed ID: 25629735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.
    Suehiro Y; Wong CW; Chirieac LR; Kondo Y; Shen L; Webb CR; Chan YW; Chan AS; Chan TL; Wu TT; Rashid A; Hamanaka Y; Hinoda Y; Shannon RL; Wang X; Morris J; Issa JP; Yuen ST; Leung SY; Hamilton SR
    Clin Cancer Res; 2008 May; 14(9):2560-9. PubMed ID: 18451217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation alterations in urothelial carcinoma.
    Neuhausen A; Florl AR; Grimm MO; Schulz WA
    Cancer Biol Ther; 2006 Aug; 5(8):993-1001. PubMed ID: 16775427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of LGALS4 correlates with poor prognosis in patients with urothelial carcinoma.
    Wu MM; Li CF; Lin LF; Wang AS; Pu YS; Wang HH; Mar AC; Chen CJ; Lee TC
    Oncotarget; 2017 Apr; 8(14):23787-23802. PubMed ID: 28423602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
    Catto JW; Azzouzi AR; Rehman I; Feeley KM; Cross SS; Amira N; Fromont G; Sibony M; Cussenot O; Meuth M; Hamdy FC
    J Clin Oncol; 2005 May; 23(13):2903-10. PubMed ID: 15753461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements.
    Kunze E; Von Bonin F; Werner C; Wendt M; Schlott T
    Int J Mol Med; 2006 Jan; 17(1):3-13. PubMed ID: 16328005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
    Rose M; Schubert C; Dierichs L; Gaisa NT; Heer M; Heidenreich A; Knüchel R; Dahl E
    Epigenetics; 2014 Dec; 9(12):1626-40. PubMed ID: 25625847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.